The new facility in Grand Rapids, MI, is part of the CDMO’s aggressive expansion plan.
US-based Grand River Aseptic Manufacturing (GRAM), a parenteral contract, development, and manufacturing organization (CDMO), has completed a $60-million expansion project in Grand Rapids, MI, and recently began occupancy at the site, the company announced in a June 30, 2020 press release.
With the expansion completed, the CDMO opened its new large-scale aseptic fill/finish facility in Grand Rapids, which more than triples its existing footprint. The added capacity, updated technologies, and state-of-the-art equipment provide flexible solutions for complex sterile injectables.
The new facility is part of the GRAM campus and is the third fill/finish facility for the company, giving it more than 100,000 ft2 of dedicated space that features:
Related Content:GMPs/Validation Whitepapers | Outsourcing | Manufacturing | Manufacturing, Aseptic Processing | News | Facility Design and Engineering | Manufacturing, Fill/Finish | Supplier News | Funding and Investments | Cleanroom Equipment and Supplies | Manufacturing, Liquid Drug Products | Manufacturing, Parenterals and Injectables | Formulation and Drug Delivery, Parenterals